(RTTNews) - Global medical technology company Smith+Nephew (SNN, SN.L), on Wednesday ... with sustained improvement in US Hip and Knee Implants, as well as strong growth in Other Reconstruction ...

LONDON (dpa-AFX) - Global medical technology company Smith+Nephew (SNN, SN.L), on Wednesday ... with sustained improvement in US Hip and Knee Implants, as well as strong growth in Other ...

Smith & Nephew PLC designs, manufactures, and markets orthopedic devices and wound-care solutions. Its products include knee replacements, hip implants, nails, fixation devices, arthroscopy tools and ...

Smith & Nephew reported its first-quarter 2025 earnings, showcasing a revenue of $1.4 billion, with underlying growth at 3.1%, surpassing its guidance. The company faced a 1.2% reported growth due ...

Smith & Nephew reported its first-quarter 2025 earnings, showcasing a revenue of $1.4 billion, with underlying growth at 3.1%, surpassing its guidance. The company faced a 1.2% reported growth due to ...

At this point some shareholders may be questioning their investment in Smith & Nephew plc (LON:SN.), since the last five years saw the share price fall 36%. Unfortunately the share price momentum ...

Under the Agreement, Smith+Nephew will market and sell CENTRIO Platelet-Rich Plasma System, their own branded version of Nuo’s underlying Aurix ® System to the United States wound care market.

If the arthroscopic surface is delaminated, we debride it and perform a core decompression as a palliative procedure before total hip arthroplasty. In the future, contrast MRI scans may be able to ...